1428639-89-7

Upstream product

• 1195-09-1 5-methyl-2-methoxyphenol 
• 518034-14-5 (3-isopropoxy-4-methoxyphenyl)methanol 
• 4383-06-6 3-hydroxy-4-methoxybenzyl alcohol 

Downstream Products

• 1428639-90-0 methyl 5-(2-bromo-5-isopropoxy-4-methoxybenzyloxy)-2'-fluorobiphenyl-2-carboxylate 
• 1428639-31-9 3-(2-fluorophenyl)-N-((R)-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl)-8-isopropoxy-9-methoxy-6H-benzo[c]chromene-2-carboxamide 
• 1428639-93-3 methyl 3-(2-fluorophenyl)-8-hydroxy-9-methoxy-6H-benzo[c]chromene-2-carboxylate 
• 1428639-94-4 3-(2-fluorophenyl)-8-hydroxy-9-methoxy-6H-benzo[c]chromene-2-carboxylic acid 
• 1428639-33-1 3-(2-fluorophenyl)-8-hydroxy-N-((R)-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl)-9-methoxy-6H-benzo[c]chromene-2-carboxamide 
• 1428639-95-5 methyl 3-(2-fluorophenyl)-9-methoxy-8-(2-methoxyethoxy)-6H-benzo[c]chromene-2-carboxylate 
• 1428639-96-6 3-(2-fluorophenyl)-9-methoxy-8-(2-methoxyethoxy)-6H-benzo[c]chromene-2-carboxylic acid 
• 1428639-35-3 3-(2-fluorophenyl)-N-((R)-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl)-9-methoxy-8-(2-methoxyethoxy)-6H-benzo[c]chromene-2-carboxamide 
• 1428639-99-9 methyl 3-(2-fluorophenyl)-9-methoxy-8-(trifluoromethylsulfonyloxy)-6H-benzo[c]chromene-2-carboxylate 
• 1428640-01-0 methyl-3-(2-fluorophenyl)-9-methoxy-8-(pyridin-3-yl)-6H-benzo[c]chromene-2-carboxylate 
• 1428640-02-1 3-(2-fluorophenyl)-9-methoxy-8-(pyridin-3-yl)-6H-benzo[c]chromene-2-carboxylic acid 
• 1428639-41-1 3-(2-fluorophenyl)-N-((R)-1-hydroxy-3-(1H-indol-3-yl)propan-2-yl)-9-methoxy-8-(pyridin-3-yl)-6H-benzo[c]chromene-2-carboxamide 

Relevant academic research and scientific papers

Preparation method of FSHR antagonist having benzo-1,4-dioxacyclohexadienone structure

The invention discloses a preparation method of an FSHR antagonist having a benzo-1,4-dioxacyclohexadienone structure, and belongs to the technical field of synthesis of medicine intermediates. A reaction equation involved in the preparation is shown in t

FSH RECEPTOR ANTAGONISTS

The invention relates to FSH receptor antagonist according to general formula I or a pharmaceutically acceptable salt thereof and to a pharmaceutical composition containing the same. The compounds can be used for the treatment and prevention of endometriosis, for the treatment and prevention of pre-menopausal and peri-menopausal hormone-dependent breast cancer, for contraception, and for the treatment of uterine fibroids and other menstrual-related disorders.